If you had a medical account in collections or delinquency for services performed by either Quest Diagnostics, Clinical Pathology Laboratories (CPL), Labcorp or Bioreference between August 1, 2018 and March 30, 2019, your personal information may have been compromised. To protect yourself, contact FDAzar Immediately at (855) 622-7613 or email us at firstname.lastname@example.org For A Free Consultation.
Summary of the Data Breach
In May 2019, American Medical Collection Agency (AMCA), a billing services vendor for Quest Diagnostics, CPL, Labcorp and Bioreference, notified the companies that an unauthorized user gained access to information on nearly 19 million patients, including credit card numbers, bank account information, social security numbers, and medical data. The unauthorized user had access to this information between August 1, 2018 and March 30, 2019.
On June 3, 2019, Quest Diagnostics publicly announced that the unauthorized user gained access to information on nearly 11.9 million of its patients. That same day, Bioreference, a subsidiary of OPKO Health, publicly announced that 6,600 of its patients were affected by the AMCA breach. On June 5, 2019, LabCorp publicly announced that 7.7 million of its patients were also affected by the AMCA breach.
On July 15, 2019, CPL publicly revealed that it too was impacted by the AMCA breach, stating that approximately “2.2 million patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information, and treatment provider information” exposed by the AMCA breach. On top of that information, an additional 34,500 CPL patients may have had their “credit card or banking information” exposed as well.
You may have a claim against AMCA, Quest, LabCorp, Bioreference, and/or CPL if you had a medical account in collections or delinquency for services performed by one of these companies between August 1, 2018 and March 30, 2019. Contact FDAzar immediately at (855) 622-7613 or email us at email@example.com For A Free Consultation.
FDAzar Files Class Action Lawsuit Against Quest Diagnostics
On June 28, 2019, FDAzar filed a class action lawsuit in the United States District Court for the District of Colorado on behalf of patients who entrusted their personal information—including Social Security numbers, bank account, and credit card information, and health data—to Quest. The lawsuit contends that Quest failed to heed warnings that the medical industry was increasingly becoming a “prime target for hackers.”
“Quest failed to properly monitor AMCA….to ensure that adequate safeguards were in place to protect its patients’ [personal information] and that those safeguards were properly monitored,” the complaint states.
In addition to credit card fraud, identity thieves can use personal information for a variety of online phishing scams, as well as to obtain bogus tax refunds and government benefits.
The case is Raben v. Quest Diagnostics, Inc., Case No. 1:19-cv-01889, U.S. District Court, Colorado
Submit Your Information
We Can Help You Today